StonvexLoading…
StonvexStonvexStonvexCore line items from UTL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $216.90M | $536.00M | $374.50M | $273.40M |
Operating Income | $55.90M | $101.20M | $66.50M | $59.50M |
Net Income | $33.20M | $50.20M | $31.20M | $31.50M |
EPS (Diluted) | $1.85 | $2.97 | $1.89 | $1.94 |
Total Assets | $2.16B | $2.13B | $1.94B | $1.89B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $16.90M | $15.60M | $14.60M | $8.50M |
Free Cash Flow OCF − CapEx | $17.70M | $-53.80M | $-17.50M | $21.50M |
Shares Outstanding | 17.99M | 17.92M | 17.90M | 16.29M |